← Back to Search

Smoke-Free Policy Support for Smoking Cessation

N/A

Recruiting

Led By Diana Hernández, PhD

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Building

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test two ways to reduce exposure to secondhand smoke in residential buildings. One targets all building residents, while the other targets smokers specifically, with the goal of reducing smoking and exposure to secondhand smoke.

Who is the study for?

This trial is for adults over 18 living in certain NYCHA buildings in Manhattan and the Bronx, who are there at least 5 days a week and not moving within two years. Smokers and non-smokers can join but must not have severe health issues that affect consent or participation.

What is being tested?

The study tests two strategies to cut down secondhand smoke: one encourages all residents to support smoke-free policies (resident endorsement), while the other helps smokers reduce or quit smoking by changing where they smoke.

What are the potential side effects?

Since this trial involves behavioral interventions like policy endorsement and smoking reduction rather than medication, it does not have typical medical side effects. However, participants may experience stress or discomfort from lifestyle changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I'm sorry, but this is not a clinical trial exclusion criterion. Can you please provide me with the correct criterion so I can rewrite it for you?

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in number of cigarettes smoked per day

Change in salivary cotinine

Change in secondhand smoke exposure

Secondary study objectives

Change in number of cigarette butts

Change in number of hours of secondhand smoke exposure

Change in number of participants with secondhand smoke observations

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Compliance through resident endorsementExperimental Treatment1 Intervention

Buildings assigned will be targeted for a series of 2 in-residence programs that involve community forums and the creative arts to garner resident endorsements of smoke-free living environments. Premised on resident engagement, this arm seeks to impact social and physical dimensions of the residential environment to achieve compliance. The sessions will: 1) inform residents of risks associated with smoking and secondhand smoke; 2) identify reasons to have a smoke-free home, 3) ask residents to sign a pledge on paper and/or virtually; 4) display smoke-free signage on doors and/or social media pages with an original hashtag (#Smokefree\[building address\]); and 5) refer residents to the Smoke-free NYCHA website for information on the policy and existing cessation resources.

Group II: Compliance through reduction/cessation plus resident endorsement (combined)Experimental Treatment2 Interventions

The combined intervention will be carried out in the buildings assigned to this RCT arm, which will provide in-residence programs based on the resident endorsement treatment and the smoking relocation/cessation treatment. Both will occur simultaneously with one geared toward all building residents (resident endorsement) and the other targeting smokers (smoking relocation/cessation) with the goal of reducing both personal smoking and secondhand smoke exposure.

Group III: Compliance through reduction (relocation and reduction of personal smoking) and cessationExperimental Treatment1 Intervention

Smokers will be referred by the survey team to peer educators from a community-based organization trained to provide peer to peer health education including tobacco cessation support. The peer educator will coordinate smoking cessation support, including serving as a liaison between participant and research team, providing information regarding the smoke-free policy and opportunities for relocation, and connecting participant to access to tobacco replacement therapy and/or physician support if deemed appropriate.

Group IV: Standard NYCHA approach (control)Active Control1 Intervention

Buildings and study participants assigned to this arm will be recruited and followed over a 12-month period to assess outcomes. No additional programs or services will be delivered to the buildings or residents assigned to this arm beyond standard programs that NYCHA may provide to support the smoke-free mandate. Field staff will document any policy-related signage, activities or information to which these participants are exposed.

0 / 1Eligibility criteria met